Literature DB >> 3377207

I-653 resists degradation in rats.

D D Koblin1, E I Eger, B H Johnson, K Konopka, L Waskell.   

Abstract

The ability of rats pretreated with phenobarbital to metabolize a new volatile anesthetic, I-653, was compared with the metabolism of halothane, isoflurane, and methoxyflurane. Each anesthetic was administered for 2 hours at 1.6 MAC (inspired). Control rats were given phenobarbital but not exposed to an anesthetic. In rats pretreated with phenobarbital and exposed to I-653, fluoride ion concentrations in serum and excretion of fluoride ion and organic fluoride in the urine were almost indistinguishable from values measured in control rats. In contrast, rats pretreated with phenobarbital metabolized small but significant amounts of isoflurane. In rats pretreated with ethanol and exposed to I-653, the 24-hour excretion of urinary organic fluoride was nearly ten times greater than that observed in control rats. Marked increases in organic fluoride (as high as 1000 times control values) and/or fluoride ion were found in serum and/or urine after anesthesia of phenobarbital-pretreated rats with halothane or methoxyflurane. The relative stability of I-653 indicates that it may possess minimal toxic properties.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3377207

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  8 in total

1.  Metabolism of desflurane and isoflurane to fluoride ion in surgical patients.

Authors:  R M Smiley; E Ornstein; E J Pantuck; C B Pantuck; R S Matteo
Journal:  Can J Anaesth       Date:  1991-11       Impact factor: 5.063

2.  Desflurane selectively suppresses long-latency cortical neuronal response to flash in the rat.

Authors:  Anthony G Hudetz; Jeannette A Vizuete; Olga A Imas
Journal:  Anesthesiology       Date:  2009-08       Impact factor: 7.892

Review 3.  Sevoflurane. A review of its pharmacodynamic and pharmacokinetic properties and its clinical use in general anaesthesia.

Authors:  S S Patel; K L Goa
Journal:  Drugs       Date:  1996-04       Impact factor: 9.546

4.  Influence of desflurane, isoflurane and halothane on regional tissue perfusion in dogs.

Authors:  J C Hartman; P S Pagel; L T Proctor; J P Kampine; W T Schmeling; D C Warltier
Journal:  Can J Anaesth       Date:  1992-10       Impact factor: 5.063

Review 5.  Desflurane. A review of its pharmacodynamic and pharmacokinetic properties and its efficacy in general anaesthesia.

Authors:  S S Patel; K L Goa
Journal:  Drugs       Date:  1995-10       Impact factor: 9.546

Review 6.  Desflurane clinical pharmacokinetics and pharmacodynamics.

Authors:  J E Caldwell
Journal:  Clin Pharmacokinet       Date:  1994-07       Impact factor: 6.447

Review 7.  Adverse effects of general anaesthetics.

Authors:  M C Berthoud; C S Reilly
Journal:  Drug Saf       Date:  1992 Nov-Dec       Impact factor: 5.606

8.  Desflurane - revisited.

Authors:  Mukul Chandra Kapoor; Mahesh Vakamudi
Journal:  J Anaesthesiol Clin Pharmacol       Date:  2012-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.